Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase

Medicine & Life Sciences

• uracil phosphoribosyltransferase 100%
• Cytosine Deaminase 86%
• Endostatins 78%
• Drug Therapy 32%
• Flucytosine 30%
• Fluorouracil 26%
• Neoplasms 17%
• Vascular Endothelial Growth Factor A 14%
• Bevacizumab 12%
• Endothelial Cells 8%
• Neoplasm Metastasis 6%
• Vascular Endothelial Growth Factor Receptor 6%
• Therapeutics 6%
• Cardiotoxicity 6%
• Prodrugs 6%
• Growth 5%
• United States Food and Drug Administration 5%
• Drug Delivery Systems 5%
• Antineoplastic Agents 5%
• Colorectal Neoplasms 4%
• Lung Neoplasms 4%
• Breast 4%
• Poisons 4%
• Homeostasis 4%
• Heart Failure 4%
• Animal Models 4%
• Phenotype 3%
• Pharmaceutical Preparations 2%
• Proteins 2%